Cargando…
15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE(2)/PPARγ-mediated activation of p21(WAF1/Cip1)
15-hydroxyprostaglandin dehydrogenase (15-PGDH) is a key enzyme in prostaglandin metabolism. This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-PGE(2)/PPARγ/p21(WAF1/Cip1) signaling pathway. Forced overexpression of 15-PGDH i...
Autores principales: | Lu, Dongdong, Han, Chang, Wu, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912217/ https://www.ncbi.nlm.nih.gov/pubmed/23542179 http://dx.doi.org/10.1038/onc.2013.69 |
Ejemplares similares
-
Epigenetic Regulation of p21(cip1/waf1) in Human Cancer
por: Ocker, Matthias, et al.
Publicado: (2019) -
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
por: Smith, Julianne N. P., et al.
Publicado: (2020) -
Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
por: Ito, Y., et al.
Publicado: (1996) -
Regenerative Response in Ischemic Brain Restricted by p21(cip1/waf1)
por: Qiu, Jianhua, et al.
Publicado: (2004) -
p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin
por: Molnar, Zoltan, et al.
Publicado: (2014)